Hannah Minor, M.S.

Hannah earned a B.S. in General Biology (minor in Music) from George Washington University, pursuing the pre-med track. After two years in a medical clinic during the COVID-19 pandemic, her interests shifted to immunology and biomedical research. Drawn to computational biology, she completed an M.S. in Bioinformatics and began her research career as a postbaccalaureate fellow in the Molecular Imaging Branch at the National Cancer Institute (NIH).

At NCI, Hannah conducted in vivo research using mouse models to investigate the roles of monocytes and macrophages within the tumor microenvironment. Her work incorporated radiolabeling and PET/CT imaging to study immune cell dynamics, resulting in her first first-author publication. She then joined Arcellx to study CAR T-cell therapies via flow cytometry, and later joined IO Biotech, where she helped develop a novel T-cell cancer vaccine using cell culture, ELISAs, ELISpot assays, and flow cytometry.